SCHEMBL601767

SCHEMBL601767

CCCCCOc1cc[n+]([O-])cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.40
THRB P10828 2/20 0.37
THRA P10827 1/20 0.37
S1PR3 Q99500 2/20 0.37
MAPT P10636 4/20 0.36
RAD52 P43351 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
APAF1 O14727 1/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NR1I2 O75469 1/20 0.36
CHRM2 P08172 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600103 0.90 GPR84 (0.37) MAPTMEN1KMT2ANPSR1HTT
SCHEMBL600127 0.85 GPR84 (0.36) MEN1KMT2AMAPK1HTTLMNA
SCHEMBL599996 0.84 GPR84 (0.34) MAPTHTTTDP1GPR84CYP2C19
SCHEMBL601078 0.84 ALDH1A1 (0.42) ESR1ALDH1A1KDM4EGPR84CYP2C19
SCHEMBL2983769 0.73 MAPT (0.36) ESR1THRBS1PR3MAPTRAD52
SCHEMBL2984114 0.72 MEN1 (0.38) ESR1S1PR3MAPTRAD52MEN1
SCHEMBL2984245 0.72 MEN1 (0.38) ESR1S1PR3MAPTRAD52MEN1
SCHEMBL2992892 0.72 MEN1 (0.38) ESR1S1PR3MAPTRAD52MEN1
SCHEMBL2985373 0.72 MEN1 (0.38) ESR1S1PR3MAPTRAD52MEN1
SCHEMBL2990341 0.72 MEN1 (0.38) ESR1S1PR3MAPTRAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102378761-A Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action ARIGEN PHARMACEUTICALS INC 2012-03-14 CN disclosed
EP-2420500-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION aRigen Pharmaceuticals, Inc. (JP) 2012-02-22 EP disclosed
US-20120041030-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION LINK GENOMICS, INC. (JP) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041030-A1 PYRIDINE THIO DERIVATIVE, AND PHARMACEUTICAL COMPOSITION WHICH CONTAINS SAME AND HAS ANTI-HELICOBACTER PYLORI ACTION TPMT, TST, PTPN11 ESR1 2796/4885THRB 359/4885THRA 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.